Our results showed that LINC00240 plays a critical role in promoting GC cell proliferation and invasion via modulating miR-338-5p/METTL3 axis, which enriches the regulatory network of LINC00240 and provides potential therapeutic targets for GC treatment. This evidence concerns the gene METTL3 and gastric cancer.